Effect of postmenopausal hormone replacement therapy on lipoprotein and homocysteine levels in Chinese women

Molecular and Cellular Biochemistry

Volumn 225, Issue 1-2, 2001, Pages 129-134

  Man, R Y K ^a   Ting, L K F ^a   Fan, S ^b   Lau, M M H ^b   Siow, Y L ^a   Chung, Y H ^a   K, O ^c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b Hong Kong Coll of Family Physicians   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Estrogen; Homocysteine; Hormone replacement therapy; Lip proteins; Progestin

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; CONJUGATED ESTROGEN; ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTROFEM; ESTROGEN; GESTAGEN; HOMOCYSTEINE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; EPIDEMIOLOGY; ESTROGEN THERAPY; EVALUATION; FEMALE; HONG KONG; HORMONE SUBSTITUTION; HUMAN; LIPOPROTEIN BLOOD LEVEL; LONG TERM CARE; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREMENOPAUSE;

ADULT; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; CHINA; CHOLESTEROL ESTERS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; HOMOCYSTEINE; HUMANS; LIPOPROTEINS; MIDDLE AGED; POSTMENOPAUSE; PROGESTINS; TRIGLYCERIDES;

EID: 0034750734     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1017405507246     Document Type: Article

References (32)

1. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study
2. Menopause and the risk of coronary heart disease in women
3. Increased risk of atherosclerosis in women after the menopause
4. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study
5. Hormone therapy to prevent disease and prolong life in postmenopausal women
6. Impact of postmenopausal hormone therapy on cardiovascular events and cancer: Pooled data from clinical trials
7. The pathogenesis of atherosclerosis: A perspective for the 1990s
8. Clinical pharmacology of estrogens: Cardiovascular actions and cardioprotective benefits of replacement therapy in postmenopausal women
9. Effects of hormone replacement therapy on cardiovascular risk factors in postmenopausal women
10. Changes in the lipoprotein profile in postmenopausal women receiving hormone replacement therapy
11. Serum lipids in postmenopausal or perimenopausal women using estrogen alone, estrogen with levonorgestrel, or estrogen with norethisterone, compared with nonusers: Results from a cross-sectional study in two 1985-1988
12. Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women
13. Relationship between serum estradiol levels and the increases in high-density lipoprotein levels in postmenopausal women treated with oral estradiol
14. Hyperhomocysteinemia: An independent risk factor for vascular disease
15. Homocysteine and vascular disease
16. Homocyst(e)ine: An important risk factor for atherosclerotic vascular disease
17. Homocysteine and cardiovascular disease
18. Homocysteine and atherothrombosis
19. Atherosclerosis risk factors: The possible role of homocysteine
20. The effect of age on cardiovascular risk factors in Chinese women
21. Role of lecithin:cholesterol acyltransferase and apolipoprotein A-I in cholesterol esterification in lipoprotein-X in vitro
22. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge
23. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia. An effect reversible with vitamin C therapy
24. The Writing Group for the PEPI Trial: Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women
25. A randomized controlled study of the effects of 17beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women
26. Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection
27. Homocysteine: An emerging age-related cardiovascular risk factor
28. Total homocysteine and estrogen status indicators in the Third National Health and Nutrition Examination Survey
29. Increased plasma homocysteine after menopause
30. The effect of sequential three-monthly hormone replacement therapy on several cardiovascular risk estimators in postmenopausal women
31. Oral estrogen improves serum lipids, homocysteine and fibrinolysis in elderly men
32. Estrogen replacement therapy and cardiovascular protection: Lipid mechanisms are the tip of an iceberg